Vita Coco (NASDAQ: COCO) chair gets performance options and RSU stock

Rhea-AI Filing Summary

Vita Coco Company, Inc. Executive Chairman Michael Kirban reported equity awards rather than open‑market trades. He acquired performance stock options covering 185,133 shares at 16.91 per share after specified performance conditions were met, and received 25,945 common shares via restricted stock units that vest in four equal annual installments if he remains in continuous service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kirban Michael

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		A(1)		25,945	A	$0	153,574	D
Common Stock								1,479,049	I	by M. Kirban 2010(2)
Common Stock								615,681	I	by M. Kirban Revoc(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Options	$16.91	02/20/2026		A		185,133		02/20/2026	03/10/2033(4)	Stock Option (Right to Buy)	185,133	$16.91	185,133	D
Non-Qualified Stock Option (Right to Buy)	$10.178							(5)	12/16/2029	Common Stock	546,000		546,000	D
Non-Qualified Stock Option (Right to Buy)	$10.178							(5)	01/11/2031	Common Stock	40,950		40,950	D
Non-Qualified Stock Option (Right to Buy)	$15							(6)	10/21/2031	Common Stock	298,507		298,507	D
Non-Qualified Stock Option (Right to Buy)	$16.91							(7)	03/10/2033	Common Stock	46,875		46,875	D
Non-Qualified Stock Option (Right to Buy)	$26.18							(8)	03/04/2034	Common Stock	62,743		62,743	D
Non-Qualified Stock Option (Right to Buy)	$32.78							(9)	03/03/2035	Common Stock	70,715		70,715	D

Explanation of Responses:

1. The Reporting Person was granted restricted stock units that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be withheld to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.

2. These shares are held by the Michael Kirban 2010 Trust.

3. These shares are held by the Michael Kirban Revocable Trust.

4. The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 185,133 shares on February 20, 2026.

5. The stock option is fully vested and currently exercisable.

6. The stock option vests in four equal annual installments beginning on November 27, 2022.

7. The stock option vests in four equal annual installments beginning on March 10, 2024.

8. The stock option vests in four equal annual installments beginning on March 4, 2025.

9. The Stock Option vests in four equal annual installments beginning in March 3, 2026.

	Alison Klein, attorney-in-fact for Michael Kirban	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Vita Coco (COCO) Executive Chairman Michael Kirban report on this Form 4?

Michael Kirban reported equity awards, not open-market trades. He acquired performance stock options on 185,133 shares and 25,945 common shares via restricted stock units, both tied to service and, for the options, to previously satisfied performance conditions.

How many Vita Coco (COCO) performance stock option shares did Michael Kirban acquire?

He acquired performance stock options covering 185,133 shares. Footnotes state that required performance conditions were satisfied, causing vesting of these options as of February 20, 2026, with an exercise price of 16.91 per share.

What restricted stock unit grant did Michael Kirban receive from Vita Coco (COCO)?

He received 25,945 common shares through restricted stock units. These units vest in four equal annual installments on each anniversary of the grant date, provided he remains in continuous service, and shares may be withheld on vesting to cover tax obligations.

Were there any Vita Coco (COCO) share sales by Michael Kirban in this Form 4?

No share sales were reported. The filing shows only equity awards and holdings, including performance options and restricted stock units, plus existing common stock positions held directly and indirectly through the Michael Kirban 2010 Trust and the Michael Kirban Revocable Trust.

How are Michael Kirban’s indirect Vita Coco (COCO) holdings structured?

Indirect holdings are shown as common stock held by the Michael Kirban 2010 Trust and the Michael Kirban Revocable Trust. The Form 4 lists these as indirect ownership, indicating the shares are owned through these trusts rather than directly in his personal name.